{"id":686756,"date":"2022-09-19T21:19:52","date_gmt":"2022-09-20T01:19:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/"},"modified":"2022-09-19T21:19:52","modified_gmt":"2022-09-20T01:19:52","slug":"curis-announces-date-for-the-2nd-annual-vista-symposium","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/","title":{"rendered":"Curis Announces Date for the 2nd Annual VISTA Symposium"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">\n        <i>Industry experts in immuno-oncology will gather to discuss VISTA on <span class=\"xn-chron\">September 23, 2022<\/span><\/i>\n      <\/p>\n<p class=\"prntac\">\n        <i>Symposium hosted by <span class=\"xn-person\">Randolph Noelle<\/span>, Ph.D.<\/i>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">LEXINGTON, Mass.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\">Sept.\u00a019, 2022<\/span> \/PRNewswire\/ &#8212; Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3653076-1&amp;h=1224003970&amp;u=https%3A%2F%2Fwww.eventbrite.com%2Fmyevent%3Feid%3D374510088757&amp;a=2nd+Annual+VISTA+Symposium\" target=\"_blank\" rel=\"nofollow noopener\">2<sup>nd<\/sup> Annual VISTA Symposium<\/a> will take place virtually on\u00a0September 23,\u00a09:<span class=\"xn-chron\">00am-1:00pm ET<\/span>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg\" title=\"(PRNewsfoto\/Curis, Inc.)\" alt=\"(PRNewsfoto\/Curis, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>The event will be hosted by\u00a0Randolph Noelle, Ph.D., Active Emeritus Professor of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at\u00a0Dartmouth. Global leaders in immuno-oncology will gather at the Symposium to discuss the VISTA checkpoint, its role in cancer, and the latest VISTA research and therapeutic development.<\/p>\n<p>&#8220;Curis is pleased to continue its sponsorship of the Annual VISTA Symposium,&#8221; said <span class=\"xn-person\">James Dentzer<\/span>, President and Chief Executive Officer of Curis. &#8220;As the global leader in VISTA development, we are honored to provide a forum for discussing the progress we&#8217;re seeing with CI-8993, our own VISTA program, as well as programs from other companies and academic labs, as we collectively advance the forefront of VISTA research and development for the benefit of patients living with cancer.&#8221;<\/p>\n<p>The virtual event features agenda topics including:<\/p>\n<ul type=\"disc\">\n<li>VISTA Biology<\/li>\n<ul type=\"disc\">\n<li>Biology Overview<\/li>\n<li>VISTA ligands and counterreceptors<\/li>\n<\/ul>\n<li>Role of VISTA in Tumor Immune Evasion<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>VISTA Targeting<\/li>\n<ul type=\"disc\">\n<li>The PK\/PD complexities of target mediated disposition<\/li>\n<li>PET Imaging of VISTA targeting<\/li>\n<\/ul>\n<li>Clinical Opportunities and Questions<\/li>\n<ul type=\"disc\">\n<li>Biomarkers, pathways and tumor subsets<\/li>\n<li>Anti-VISTA antibody in combination with radiation therapy<\/li>\n<li>Translational immunology in cutaneous malignancies<\/li>\n<\/ul>\n<li>Anti-VISTA Therapeutic Strategies<\/li>\n<\/ul>\n<p>To learn more about the symposium and register to attend, please visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3653076-1&amp;h=1999875481&amp;u=https%3A%2F%2Fbit.ly%2FVISTA22&amp;a=https%3A%2F%2Fbit.ly%2FVISTA22\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/bit.ly\/VISTA22<\/a>.<\/p>\n<div class=\"wcag-arialevel-3\" style=\"font-size: 1.17em;font-weight: bold\" role=\"heading\">\n        <b>About Curis, Inc.<\/b>\n      <\/div>\n<p>Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. In 2015, Curis entered into a collaboration with Aurigene in the areas of immuno-oncology and precision oncology. As part of this collaboration, Curis has exclusive licenses to oral small molecule antagonists of immune checkpoints including the VISTA\/PDL1 antagonist CA-170, and the TIM3\/PDL1 antagonist CA-327, as well as the IRAK4 kinase inhibitor, emavusertib (CA-4948). Emavusertib is currently undergoing testing in the Phase 1\/2 TakeAim Lymphoma trial, in patients with hematologic malignancies, such as non-Hodgkin&#8217;s lymphoma and other B cell malignancies, both as a monotherapy and in combination with BTK inhibitor ibrutinib, and the Phase 1\/2 TakeAim Leukemia trial in patients with AML and MDS, for which it has received Orphan Drug Designation from the U.S. Food and Drug Administration. The FDA has placed a partial clinical hold on the TakeAim Leukemia trial during which no new patients will be enrolled in the combination phase (Phase <span class=\"xn-money\">1b<\/span>) of emavusertib with azacitidine or venetoclax and expansion phase (Phase 2a), and current study participants benefiting from treatment may continue to be treated with emavusertib at doses of 300mg BID or lower. In addition, Curis is engaged in a collaboration with ImmuNext for the development of CI-8993, a monoclonal anti-VISTA antibody, which is currently undergoing testing in a Phase 1 trial in patients with solid tumors. Curis is also party to a collaboration with Genentech, a member of the Roche Group, under which Genentech and Roche are commercializing Erivedge\u00ae for the treatment of advanced basal cell carcinoma. For more information, visit Curis&#8217;s website at <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3653076-1&amp;h=3390578397&amp;u=https%3A%2F%2Fnam12.safelinks.protection.outlook.com%2F%3Furl%3Dhttp%253A%252F%252Fwww.curis.com%252F%26data%3D05%257C01%257Ckat.morano%2540sternir.com%257C5ee57c4d9b534b8a5f1108da8557bfe6%257Cb71ff3f628164ca8a9b938f820f91ad1%257C0%257C0%257C637968909169780025%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C3000%257C%257C%257C%26sdata%3Dz%252FOPgdUQ9QoxOWCc2aeEjvsIBgr1kvWDB51Le950%252FUw%253D%26reserved%3D0&amp;a=www.curis.com\" target=\"_blank\" rel=\"nofollow noopener\">www.curis.com<\/a>.\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE77906&amp;sd=2022-09-19\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/curis-announces-date-for-the-2nd-annual-vista-symposium-301627719.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/curis-announces-date-for-the-2nd-annual-vista-symposium-301627719.html<\/a><\/p>\n<p>SOURCE  Curis, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NE77906&amp;Transmission_Id=202209192116PR_NEWS_USPR_____NE77906&amp;DateId=20220919\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Industry experts in immuno-oncology will gather to discuss VISTA on September 23, 2022 Symposium hosted by Randolph Noelle, Ph.D. LEXINGTON, Mass. , Sept.\u00a019, 2022 \/PRNewswire\/ &#8212; Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the 2nd Annual VISTA Symposium will take place virtually on\u00a0September 23,\u00a09:00am-1:00pm ET. The event will be hosted by\u00a0Randolph Noelle, Ph.D., Active Emeritus Professor of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at\u00a0Dartmouth. Global leaders in immuno-oncology will gather at the Symposium to discuss the VISTA checkpoint, its role in cancer, and the latest VISTA research and therapeutic development. &#8220;Curis is pleased to continue its sponsorship of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Curis Announces Date for the 2nd Annual VISTA Symposium&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-686756","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Curis Announces Date for the 2nd Annual VISTA Symposium - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Curis Announces Date for the 2nd Annual VISTA Symposium - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Industry experts in immuno-oncology will gather to discuss VISTA on September 23, 2022 Symposium hosted by Randolph Noelle, Ph.D. LEXINGTON, Mass. , Sept.\u00a019, 2022 \/PRNewswire\/ &#8212; Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the 2nd Annual VISTA Symposium will take place virtually on\u00a0September 23,\u00a09:00am-1:00pm ET. The event will be hosted by\u00a0Randolph Noelle, Ph.D., Active Emeritus Professor of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at\u00a0Dartmouth. Global leaders in immuno-oncology will gather at the Symposium to discuss the VISTA checkpoint, its role in cancer, and the latest VISTA research and therapeutic development. &#8220;Curis is pleased to continue its sponsorship of &hellip; Continue reading &quot;Curis Announces Date for the 2nd Annual VISTA Symposium&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-20T01:19:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Curis Announces Date for the 2nd Annual VISTA Symposium\",\"datePublished\":\"2022-09-20T01:19:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/\"},\"wordCount\":565,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/\",\"name\":\"Curis Announces Date for the 2nd Annual VISTA Symposium - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\",\"datePublished\":\"2022-09-20T01:19:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-announces-date-for-the-2nd-annual-vista-symposium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Curis Announces Date for the 2nd Annual VISTA Symposium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Curis Announces Date for the 2nd Annual VISTA Symposium - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/","og_locale":"en_US","og_type":"article","og_title":"Curis Announces Date for the 2nd Annual VISTA Symposium - Market Newsdesk","og_description":"PR Newswire Industry experts in immuno-oncology will gather to discuss VISTA on September 23, 2022 Symposium hosted by Randolph Noelle, Ph.D. LEXINGTON, Mass. , Sept.\u00a019, 2022 \/PRNewswire\/ &#8212; Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the 2nd Annual VISTA Symposium will take place virtually on\u00a0September 23,\u00a09:00am-1:00pm ET. The event will be hosted by\u00a0Randolph Noelle, Ph.D., Active Emeritus Professor of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at\u00a0Dartmouth. Global leaders in immuno-oncology will gather at the Symposium to discuss the VISTA checkpoint, its role in cancer, and the latest VISTA research and therapeutic development. &#8220;Curis is pleased to continue its sponsorship of &hellip; Continue reading \"Curis Announces Date for the 2nd Annual VISTA Symposium\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-20T01:19:52+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Curis Announces Date for the 2nd Annual VISTA Symposium","datePublished":"2022-09-20T01:19:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/"},"wordCount":565,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/","name":"Curis Announces Date for the 2nd Annual VISTA Symposium - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","datePublished":"2022-09-20T01:19:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-announces-date-for-the-2nd-annual-vista-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Curis Announces Date for the 2nd Annual VISTA Symposium"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/686756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=686756"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/686756\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=686756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=686756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=686756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}